# Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas

> **NCT02362308** · — · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 10 (actual)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **OTHER:** Adrenalectomy
- **DRUG:** mineralocorticoid receptor antagonist

## Key facts

- **NCT ID:** NCT02362308
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02362308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02362308, "Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02362308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*